Patents by Inventor Mickael Dahlstrom

Mickael Dahlstrom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 1,5-Benzothiazepines and their use as hypolipidaemics
    Patent number: 6906058
    Abstract: The present invention relates to compounds of formula (I) wherein R1 and R2 are independently selected from C1-6alkyl; one of R4 and R5 is a group of formula (IA): R3, R6, R7, R8, R9, R10 and R11 and the other of R4 and R5 are as defined within, pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and there use as ileal bile acid transport (IBAT) inhibitors for the treatment of hyperlipidaemia. Processes for their manufacture and pharmaceutical compositions containing them are also described.
    Type: Grant
    Filed: March 5, 2001
    Date of Patent: June 14, 2005
    Assignee: AstraZeneca AB
    Inventors: Ingemar Starke, Mickael Dahlström, David Blomberg
  • 1,5-Benzothiazepines and their use as hypolipidaemics
    Publication number: 20030166927
    Abstract: The present invention relates to compounds of formula (I) wherein R1 and R2 are independently selected from C1-6alkyl; one of R4 and R5 is a group of formula (IA): R3, R6, R7, R8, R9, R10 and R11 and the other of R4 and R5 are as defined within, pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and there use as ileal bile acid transport (IBAT) inhibitors for the treatment of hyperlipidaemia. Processes for their manufacture and pharmaceutical compositions containing them are also described.
    Type: Application
    Filed: September 6, 2002
    Publication date: September 4, 2003
    Inventors: Ingemar Starke, Mickael Dahlstrom, David Blomberg